Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Metabolism: Clinical and Experimental|May 22, 2012
Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese miceLinda H Wu, C Chris Huang, Sree Adhikarakunnathu, et al.Mabs|January 30, 2025
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidityJeremy Loyau, Thierry Monney, Marco Montefiori, et al.Mabs|May 10, 2019
Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)Jennifer Ahlberg, Craig Giragossian, Hua Li, et al.Journal of Medicinal Chemistry|June 9, 2016
Incorporation of Phosphonate into Benzonaphthyridine Toll-like Receptor 7 Agonists for Adsorption to Aluminum HydroxideAlex Cortez, Yongkai Li, Andrew T Miller, et al.Frontiers in Immunology|January 31, 2022
NFAM1 Promotes Pro-Inflammatory Cytokine Production in Mouse and Human MonocytesKathryn W Juchem, Anshu P Gounder, Jian Ping Gao, et al.Respiratory Research|June 3, 2009
Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in miceNicole C Stowell, Jonathan Seideman, Holly A Raymond, et al.Nature|May 21, 2020
TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9Leonhard X Heinz, JangEun Lee, Utkarsh Kapoor, et al.Mabs|July 21, 2017
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodiesRajkumar Ganesan, Ernest L Raymond, Detlev Mennerich, et al.Gastroenterology|November 20, 2018
Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal InflammationKristina Scheibe, Christina Kersten, Anabel Schmied, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel diseaseJoerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.Pageof 5